While statin drugs, which lower cholesterol production by the liver, have helped many avoid atherosclerosis not everyone can take them. A new means of dealing with artery-blocking cholesterol plaques may be on the horizon — with an old compound called cyclodextrin possibly being repurposed to do just that.
